Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 27, Issue 4, 2011, Pages 701-709

  Lloret, Ana ^a   Badia, Mari Carmen ^b   Giraldo, Esther ^a   Ermak, Gennady ^c,d   Alonso, Maria Dolores ^b   Pallardó, Federico V ^a   Davies, Kelvin J A ^c,d   Viña, Jose ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; amyloid toxicity; oxidative stress; RCAN1

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CALCINEURIN; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATASE; REACTIVE OXYGEN METABOLITE; TAU PROTEIN; TROLOX C;

ADULT; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; BRAIN CORTEX; CELL STRAIN; CELL STRESS; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; GENE EXPRESSION; GENE SILENCING; GENOTYPE; HUMAN; HUMAN EXPERIMENT; INCUBATION TEMPERATURE; LYMPHOCYTE; MITOCHONDRION; NERVE CELL; NONHUMAN; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; UPREGULATION; WISTAR RAT;

EID: 84455173610     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110890     Document Type: Article

References (29)

1. Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM (2010) Synergistic Interactions between Abeta, tau, and alpha-synuclein: Acceleration of neuropathology and cognitive decline. J Neurosci 30, 7281-7289
2. Davies KJA, Ermak G, Rothermel BA, Pritchard M, Heitman J, Ahnn J, Henrique-Silva F, Crawford D, Canaider S, Strippoli P, Carinci P, Min KT, Fox DS, Cunningham KW, Bassel-Duby R, Olson EN, Zhang Z, Williams RS, Gerber HP, Pérez-Riba M, Seo H, Cao X, Klee CB, Redondo JM, Maltais LJ, Bruford EA, Povey S, Molkentin JD, McKeon FD, Duh EJ, Crabtree GR, Cyert MS, de la Luna S, Estivill X (2007) Renaming the DSCR1/Adapt78 gene family as RCAN: Regulators of calcineurin. FASEB J 21, 3023-3028 (Pubitemid 47565558)
3. Mitchell AN, Jayakumar L, Koleilat I, Qian J, Sheehan C, Bhoiwala D, Hushmendy SF, Heuring JM, Crawford DR (2007) Brain expression of the calcineurin inhibitor RCAN1 (Adapt78). Arch Biochem Biophys 467, 185-192 (Pubitemid 350050896)
4. Harris CD, Ermak G, Davies KJA(2005) Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease. Cell Mol Life Sci 62, 2477-2486 (Pubitemid 41801100)
5. Ermak G, Davies KJA(2003) DSCR1(Adapt78)-a Janus gene providing stress protection but causing Alzheimers disease? IUBMB Life 55, 29-31 (Pubitemid 36427596)
6. Crawford DR, Leahy KP, Abramova N, Lan L, Wang Y, Davies KJA (1997) Hamster adapt78 mRNA is a Down syndrome critical region homologue that is inducible by oxidative stress. Arch Biochem Biophys 342, 6-12 (Pubitemid 27217096)
7. Norman SG, Johnson GV (1994) Compromised mitochondrial function results in dephosphorylation of tau through a calcium-dependent process in rat brain cerebral cortical slices. Neurochem Res 19, 1151-1158 (Pubitemid 24284790)
8. Lloret A, Badía MC, Mora NJ, Ortega A, Pallardó FV, Alonso MD, Viña J (2008) Gender and age-dependent differences in the mitochondrial apoptogenic pathway in Alzheimers disease. Free Radic Biol Med 44, 2019-2025
9. Ermak G, Morgan TE, Davies KJA (2001) Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimers disease. J Biol Chem 276, 38787-38794
10. Harris CD, Ermak G, Davies KJA (2007) RCAN1-1L is overexpressed in neurons of Alzheimers disease patients. FEBS J 274, 1715-1724 (Pubitemid 46426906)
11. Morais Cardoso S, Swerdlow RH, Oliveira CR (2002) Induction of cytochrome c-mediated apoptosis by amyloid beta 25-35 requires functional mitochondria. Brain Res 93, 117-125 (Pubitemid 34230515)
12. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimers. Nature 382, 120-121
13. Ermak G, Harris CD, Battocchio D, Davies KJA (2006) RCAN1 (DSCR1 or Adapt78) stimulates expression of GSK- 3beta. FEBS J 273, 2100-2109
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, StadlanEM(1984) Clinical diagnosis of Alzheimers disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimers disease. Neurology 34, 939-944 (Pubitemid 14076461)
15. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimers disease. Am J Pathol 155, 853-862 (Pubitemid 29426831)
16. Asensi M, Sastre J, Pallardo FV, Estrela JM, Vina J (1994) Determination of oxidized glutathione in blood: Highperformance liquid chromatography. Methods Enzymol 234, 367-371
17. Vallés SL, Borrás C, Gambini J, Furriol J, Ortega A, Sastre J, Pallardó FV, Viña J (2008) Oestradiol or genistein rescues neurons from amyloid beta-induced cell death by inhibiting activation of p38. Aging Cell 7, 112-118 (Pubitemid 351144607)
18. Armentero MT, Sinforiani E, Ghezzi C, Bazzini E, Levandis G, Ambrosi G, Zangaglia R, Pacchetti C, Cereda C, Cova E, Basso E, Celi D, Martignoni E, Nappi G, Blandini F (2010) Peripheral expression of key regulatory kinases in Alzheimers disease and Parkinsons disease. Neurobiol Aging. doi:10.1016/j. neurobiolaging.2010.01.004
19. Smith MA, Richey PL, Taneda S, Kutty RK, Sayre LM, Monnier VM, Perry G (1994) Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimers disease. Ann N Y Acad Sci 738, 447-454
20. Praprotnik D, Smith MA, Richey PL, Vinters HV, Perry G (1996) Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimers disease: An index of oxidative stress. Acta Neuropathol 91, 1-5
21. Cardoso SM, Santos S, Swerdlow RH, Oliveira CR (2001) Functional mitochondria are required for amyloid betamediated neurotoxicity. FASEB J 15, 1439-1441
22. Butterfield DA, Perluigi M, Sultana R (2006) Oxidative stress in Alzheimers disease brain: New insights from redox proteomics. Eur J Pharmacol 545, 39-50 (Pubitemid 44215876)
23. Ermak G, Harris CD, Davies KJA (2002) The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress. FASEB J 16, 814-824 (Pubitemid 34615130)
24. Fuentes JJ, Genesca L, Kingsbury TJ, Cunningham KW, Perez-Riba M, Estivill X, de la Luna S (2000) DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Human Mol Genet 9, 1681-1690 (Pubitemid 30427005)
25. Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, Van Leuven F (2008) Amyloid activates GSK- 3beta to aggravate neuronal tauopathy in bigenic mice. Am J Pathol 172, 786-798 (Pubitemid 351354550)
26. Alzheimer A (1907) Uber eine eigenartige Erkrankung der Hirnrinde. Allg Zeitschr Psychiatr 4, 146-148
27. Aluise CD, Robinson RA, Beckett TL, Murphy MP, Cai J, Pierce WM, Markesbery WR, Butterfield DA (2010) Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics. Neurobiol Dis 39, 221-228
28. Bradley MA, Markesbery WR, Lovell MA (2010) Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic Biol Med 48, 1570-1576
29. Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimers disease and related disorders. Nat Rev Neurosci 8, 663-672 (Pubitemid 47283144)